Marc J. Yoskowitz

Marc J. Yoskowitz

Director/Board Member en MEREO BIOPHARMA GROUP PLC .

Fortuna: - $ al 31/03/2024

Health Technology
Consumer Services
Commercial Services

Perfil

Marc J.
Yoskowitz
is currently the Chief Executive Officer at Evozyne Inc since 2023 and the Non-Executive Director at Mereo BioPharma Group Plc since 2022.
Previously, he held positions as the Senior VP-Strategy & Corporate Development at Hospira, Inc., Associate Principal at McKinsey & Co., Inc., Chief Strategy Officer & Executive Vice President at Tempus, Inc., and Chief Business Officer at Pfizer Essential Health.
He completed his undergraduate studies at Washington University in St. Louis and obtained a graduate degree from Columbia Law School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
08/02/2024 0 ( -.--% ) - $ 31/03/2024

Cargos activos de Marc J. Yoskowitz

EmpresasCargoInicio
MEREO BIOPHARMA GROUP PLC Director/Board Member 10/11/2022
Chief Executive Officer 04/01/2023
Todos los cargos activos de Marc J. Yoskowitz

Antiguos cargos conocidos de Marc J. Yoskowitz.

EmpresasCargoFin
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
HOSPIRA, INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Marc J. Yoskowitz.

Formación de Marc J. Yoskowitz.

Washington University in St. Louis Undergraduate Degree
Columbia Law School Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Marc J. Yoskowitz.

Relaciones

27

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
MEREO BIOPHARMA GROUP PLC

Health Technology

Empresas privadas5

Health Technology

Commercial Services

Consumer Non-Durables

Health Technology

Commercial Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Marc J. Yoskowitz